AUG 23, 2019 6:27 AM PDT

New hope for children's brain cancer DIPG

New research published in Nature Communications provides insight on a potential treatment for an aggressive form of brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG) which usually affects children under 10. There is currently no standard of care for DIPG as the tumor that grows in the brain stem is inoperable; and while the number of patients affected in the U.S. is only approximately 300 annually, most patients do not survive more than a year after diagnosis.

The research comes from a collaboration between scientists at Yale University, University of Iowa, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. It identifies a pathway that could disrupt the cellular process of DIPG.

DIPG develops in part because of a genetic mutation called PPM1D which affects cell growth and cell stress response. The team behind the study figured out a way to directly target PPM1D via the metabolite called NAD.

"This is really an amazing new way to attack this cancer. We found that the mutated gene PPM1D essentially sets the stage for its own demise," said senior author of the study, Michael Berens, Ph.D., a TGen Deputy Director, head of TGen's DIPG research.

"Our study's potential translational impact should lead to clinical trials and renewed hope for these families who face such a difficult diagnosis for their child," said co-senior author Charles Brenner, Ph.D., Chairman of Biochemistry at the University of Iowa.

Children diagnosed with DIPG typically do not live longer than a year after diagnosis. Photo: Pixabay

Their investigations arose because typical treatments for adult gliomas were not producing the desired results; this urged the researchers to look at the tumors from a new angle, focusing on their vulnerabilities and the role of PPM1D.

As Science Daily reports, the team discovered that “mutated PPM1D silences a gene called NAPRT, which is key to the production of the NAD metabolite. With NAPRT unavailable, the cell switches to another protein needed to create NAD called NAMPT. By using a drug that inhibits the production of NAMPT, researchers found they could essentially starve to death those cancer cells with the PPM1D mutation.”

Another senior author Ranjit Bindra, M.D., Ph.D., Associate Professor of Therapeutic Radiology at the Yale Cancer Center, commented on the hope that the discovery brings. "It is such a devastating disease, and we have been so stymied in our progress for new DIPG therapies. Many drugs have been tested with no success at all. These findings now offer new hope for children with this truly terrible disease," he said.

Sources: Science Daily, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 07, 2020
Plants & Animals
Do Tasmanian Devils Hold the Key to Tumor Inhibition?
AUG 07, 2020
Do Tasmanian Devils Hold the Key to Tumor Inhibition?
Thanks to a historic cartoon character, Tasmanian devils are commonly regarded as cantankerous and ferocious creatures. ...
AUG 10, 2020
Cancer
What fireflies' bioluminescence can teach us about mitochondria and cancer
AUG 10, 2020
What fireflies' bioluminescence can teach us about mitochondria and cancer
Researchers have developed a technique to measure mitochondria activity in cells using a molecule from fireflies. The me ...
AUG 21, 2020
Immunology
Cancer Feels the STING
AUG 21, 2020
Cancer Feels the STING
Researchers have discovered a protein that can amplify immune reactions against tumors. The stimulator of interferon gen ...
AUG 28, 2020
Cancer
Using CRISPR-Cas12a to Repair Hereditary Cancers in the Lab
AUG 28, 2020
Using CRISPR-Cas12a to Repair Hereditary Cancers in the Lab
Genome repair is one of the big-ticket research areas for the future of medicine. CRISPR-Cas9 systems can edit the genom ...
AUG 31, 2020
Cancer
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
AUG 31, 2020
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
Chemoresistance is a serious problem for many cancer therapies. Solutions to this problem are harder to come by than the ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
Loading Comments...